Business Wire

Magic Software Enterprises’ IoT Integration Solution Powered by GigaSpaces InsightEdge

11.7.2017 16:30 | Business Wire

Jaa

GigaSpaces, a provider of in-memory computing (IMC) technologies, is powering the IoT integration solutions for Magic Software Enterprises, a global provider of integration software and a broad range of software and IT services. Magic is utilizing GigaSpaces’ InsightEdge platform to turn data from sensors into real-time actionable insights as part of its integration solution, Magic xpi.

With 20.8B connected things expected to be in use worldwide by 2020, IoT offers huge potential for many industries including manufacturing, transportation, healthcare, security and more. Collecting, aggregating and analyzing this massive amount of data is imperative for enterprises looking to act on real-time insights.

InsightEdge, a fast data in-memory computing platform that converges analytical and transactional workloads in a unified open-source based software stack, streams and transforms IoT sensor data, which is operationalized through Magic xpi’s integration and intelligence engine.

Magic Software’s IoT integration solution together with InsightEdge can be leveraged for many IoT scenarios, such as predictive maintenance, anomaly detection and service optimization where telemetry is ingested, correlated and merged. The data is then transferred to Magic xpi as the orchestrator of the process for prediction and any additional required actions. The solution predicts equipment failure to ensure business continuity and optimized operations.

“Our system integration platform that has optimized business processes and evolved over the last 15 years has now become an IoT Hub, equipped with GigaSpaces’ latest product, InsightEdge,” said Yuval Lavi, Vice President of Technology & Innovation with Magic Software. “GigaSpaces enables our customers to simplify and accelerate telemetry ingestion, to gain full business value from IoT adoption.”

This is not the first collaboration between Magic and GigaSpaces. Magic has been using GigaSpaces’ XAP In-memory computing platform for years to deliver fast data streaming, aggregation and calculations. “Magic has continually built and delivered exceptional solutions for their customers, and their newest IoT integration solution is addressing a compelling requirement to manage and analyze IoT data,” said Ali Hodroj, VP of Products and Strategy for GigaSpaces. “With Magic’s latest solutions, we are enabling IoT applications to scale through open source components in the center, edge and cloud while combining hybrid transactional/analytical processing (HTAP).”

For more information, Magic and GigaSpaces will be hosting a joint webinar.
Read more at the company’s blog: blog.gigaspaces.com

About GigaSpaces
GigaSpaces provides software for in-memory computing, fast data analytics, and cloud orchestration through two product lines, InsightEdge and XAP In-Memory Computing. Hundreds of Tier-1 and Fortune-listed organizations worldwide leverage GigaSpaces technology to empower the real-time digital enterprise and accelerate digital transformation. Primary sectors include financial services, retail, transportation, telecom, and healthcare. GigaSpaces offices are located in the US, Europe and Asia. More at www.gigaspaces.com and blog.gigaspaces.com.

About Magic Software Enterprises
Magic Software Enterprises (NASDAQ: MGIC) empowers customers and partners around the globe with smarter technology that provides a multichannel user experience of enterprise logic and data.

Contact information

Fusion PR for GigaSpaces
Kayla Perkins, 646-452-7111
kayla.perkins@fusionpr.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 21:33Tiedote

The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 15:09Tiedote

Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 14:26Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s

NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 10:00Tiedote

NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve

Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 08:00Tiedote

Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme